Making headway in an attempt to bring the CorPath 200 System to market, Corindus Vascular Robotics (Natick, Massachusetts) reported that the clinical trial of the system has begun. The first PCI procedures using the system were performed at New York-Presbyterian Hospital/Columbia University Medical Center (New York) and St. Elizabeth's Medical Center (Boston) in the Percutaneous Robotic-Enhanced Coronary Intervention (PRECISE) study. (Medical Device Daily) Read More
